Related references
Note: Only part of the references are listed.Synergistic effects of IAP inhibitor LCL161 and paclitaxel on hepatocellular carcinoma cells
Aiping Tian et al.
CANCER LETTERS (2014)
JNK activation is required for TNFα-induced apoptosis in human hepatocarcinoma cells
Valerio Giacomo Minero et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2013)
Resistance to paclitaxel in hepatoma cells is related to static JNK activation and prohibition into entry of mitosis
Sunyoung Chae et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2012)
The TNF-α/ROS/HIF-1-induced Upregulation of FoxMI Expression Promotes HCC Proliferation and Resistance to Apoptosis
Limin Xia et al.
CARCINOGENESIS (2012)
Sequential Application of Anticancer Drugs Enhances Cell Death by Rewiring Apoptotic Signaling Networks
Michael J. Lee et al.
CELL (2012)
Sphingosine mediates TNFα-induced lysosomal membrane permeabilization and ensuing programmed cell death in hepatoma cells
Chiara Ullio et al.
JOURNAL OF LIPID RESEARCH (2012)
Src family kinases and paclitaxel sensitivity
Xiao-Feng Le et al.
CANCER BIOLOGY & THERAPY (2011)
Suppression of SOCS3 increases susceptibility of renal cell carcinoma to interferon-alpha
Shintaro Tomita et al.
CANCER SCIENCE (2011)
Diclofenac Inhibits Tumor Necrosis Factor-α-Induced Nuclear Factor-κB Activation Causing Synergistic Hepatocyte Apoptosis
Lisa Fredriksson et al.
HEPATOLOGY (2011)
Review article: the management of hepatocellular carcinoma
R. Cabrera et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Combination chemotherapy of doxorubicin and paclitaxel for hepatocellular carcinoma in vitro and in vivo
Cheng Jin et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
Microtubule-Targeted Chemotherapeutic Agents Inhibit Signal Transducer and Activator of Transcription 3 (STAT3) Signaling
Sarah R. Walker et al.
MOLECULAR PHARMACOLOGY (2010)
Divergent pathways for TNF and C2-ceramide toxicity in HTC hepatoma cells
Riccardo Autelli et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2009)
Dysregulation of apoptosis in hepatocellular carcinoma cells
Isabel Fabregat
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Modulation of death receptors by cancer therapeutic agents
Heath A. Elrod et al.
CANCER BIOLOGY & THERAPY (2008)
TRAIL inactivates the mitotic checkpoint and potentiates death induced by microtubule-targeting agents in human cancer cells
Mijin Kim et al.
CANCER RESEARCH (2008)
Microtubule Active Agents: Beyond the Taxane Frontier
Patrick G. Morris et al.
CLINICAL CANCER RESEARCH (2008)
SOCS3 in liver regeneration and hepatocarcinoma
Joanne Elliott
MOLECULAR INTERVENTIONS (2008)
Regulation of liver regeneration and hepatocarcinogenesis by suppressor of cytokine signaling 3
Kimberly J. Riehle et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines:: Possible mechanisms of cell resistance
O. Brenes et al.
BIOMEDICINE & PHARMACOTHERAPY (2007)
JAK/STAT3 pathway is involved in survival of neurons in response to insulin-like growth factor and negatively regulated by suppressor of cytokine signaling-3
A Yadav et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Intracellular free iron and acidic pathways mediate TNF-induced death of rat hepatoma cells
R Autelli et al.
APOPTOSIS (2005)
Effects of sequential treatments with chemotherapeutic drugs followed by TRAIL on prostate cancer in vitro and in vivo
S Shankar et al.
PROSTATE (2005)
Microtubules as a target for anticancer drugs
MA Jordan et al.
NATURE REVIEWS CANCER (2004)
Bcl-2 and Bcl-xL are important for the induction of paclitaxel resistance in human hepatocellular carcinoma cells
EY Chun et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Chemotherapeutic agents enhance TRAIL-induced apoptosis in prostate cancer cells
A Munshi et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2002)
Trail, FASL and a blocking anti-DR5 antibody augment paclitaxel-induced apoptosis in human non-small-cell lung cancer
C Odoux et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Share Paper
